Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets

Heart failure is a severe disease with an unfavorable prognosis, which requires intensification of therapy and the search for novel approaches to treatment. In this review, the physiological significance of soluble guanylate cyclase-related signaling pathway, reasons for decrease in its activity in...

Full description

Bibliographic Details
Main Authors: Zh. D. Kobalava, P. V. Lazarev
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2021-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3035
_version_ 1797882312154677248
author Zh. D. Kobalava
P. V. Lazarev
author_facet Zh. D. Kobalava
P. V. Lazarev
author_sort Zh. D. Kobalava
collection DOAJ
description Heart failure is a severe disease with an unfavorable prognosis, which requires intensification of therapy and the search for novel approaches to treatment. In this review, the physiological significance of soluble guanylate cyclase-related signaling pathway, reasons for decrease in its activity in heart failure and possible consequences are discussed. Pharmacological methods of stimulating the production of cyclic guanosine monophosphate using drugs with different mechanisms of action are considered. Data from clinical studies regarding their effectiveness and safety are presented. A promising approach is stimulation of soluble guanylate cyclase, which showed beneficial effects in preclinical studies, as well as in the recently completed phase III VICTORIA study.
first_indexed 2024-04-10T03:33:49Z
format Article
id doaj.art-2e85e34f17e94a13885fc2f90b9b87eb
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:33:49Z
publishDate 2021-10-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-2e85e34f17e94a13885fc2f90b9b87eb2023-03-13T07:23:31Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-10-0120610.15829/1728-8800-2021-30352341Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targetsZh. D. Kobalava0P. V. Lazarev1ФГАОУ ВО Российский Университет Дружбы НародовБайер, АОHeart failure is a severe disease with an unfavorable prognosis, which requires intensification of therapy and the search for novel approaches to treatment. In this review, the physiological significance of soluble guanylate cyclase-related signaling pathway, reasons for decrease in its activity in heart failure and possible consequences are discussed. Pharmacological methods of stimulating the production of cyclic guanosine monophosphate using drugs with different mechanisms of action are considered. Data from clinical studies regarding their effectiveness and safety are presented. A promising approach is stimulation of soluble guanylate cyclase, which showed beneficial effects in preclinical studies, as well as in the recently completed phase III VICTORIA study.https://cardiovascular.elpub.ru/jour/article/view/3035сердечная недостаточностьгуанилатциклазасигнальный путь
spellingShingle Zh. D. Kobalava
P. V. Lazarev
Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
Кардиоваскулярная терапия и профилактика
сердечная недостаточность
гуанилатциклаза
сигнальный путь
title Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
title_full Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
title_fullStr Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
title_full_unstemmed Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
title_short Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
title_sort nitric oxide soluble guanylate cyclase cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
topic сердечная недостаточность
гуанилатциклаза
сигнальный путь
url https://cardiovascular.elpub.ru/jour/article/view/3035
work_keys_str_mv AT zhdkobalava nitricoxidesolubleguanylatecyclasecyclicguanosinemonophosphatesignalingpathwayinthepathogenesisofheartfailureandsearchfornoveltherapeutictargets
AT pvlazarev nitricoxidesolubleguanylatecyclasecyclicguanosinemonophosphatesignalingpathwayinthepathogenesisofheartfailureandsearchfornoveltherapeutictargets